期刊文献+

胃癌血清IL-10和IL-12与肿瘤分期及血管生成的关系研究 被引量:3

下载PDF
导出
摘要 目的:探讨血清中IL-10、IL-12与胃癌病理分期及肿瘤血管形成的关系。方法:选取我院病理证实的36例胃癌患者做实验组,健康体检的28例做对照组,所有研究对象检测血清IL-10、IL-12含量,胃癌患者组织标本免疫组化表达血管内皮生长因子(VEGF)的含量并收集患者病理与临床指标。结果:胃癌患者血清IL-10含量比对照组血清中含量明显增加,胃癌分期较晚、有淋巴结转移、组织分化差的患者血清中IL-10含量比胃癌无淋巴结转移、分期与组织分化较好的患者含量高,而胃癌患者血清IL-12与之相反,且胃癌患者血清IL-10、IL-12的含量与胃癌组织中VEGF免疫组化表达相关。结论:胃癌患者血清IL-10、IL-12含量与胃癌淋巴转移、肿瘤分期、组织分化等病理参数相关,并与胃癌VEGF的促肿瘤血管新生有一定关系。
出处 《实用医技杂志》 2008年第33期4768-4770,共3页 Journal of Practical Medical Techniques
  • 相关文献

参考文献7

  • 1O’Hara RJ,Greenman J,MacDonald AW,et al.Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production[].Clinical Cancer Research.1998
  • 2Kim,J,Modlin,RL,Moy,RL,Dubinett,SM,McHugh,T,Nickoloff,BJ,Uyemura,K.I1-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response[].J Immunol.1995
  • 3Shibata M,Nezu T,Kanou H, et al.Decreased production of interleukin-12 and type 2 immune responses are marked in cachectic patients with colorectal and gastric cancer[].Journal of Clinical Gastroenterology.2002
  • 4Minagawa N,Nakayama Y,Hirata K,et al.Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer[].Anticancer Research.2002
  • 5Nishitani,MA,Sakai,T,Ishii,K,Zhang,M,Nakano,Y,Nitta,Y,Miyazaki,J,Kanayama,HO,Kagawa,S,Himeno,K.A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells[].Cancer Gene Therapy.2002
  • 6Tatsumi T,Takehara T,Kanto T et al.Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma[].Cancer Research.2001
  • 7Cavallo F,Di-Carlo E,Butera M,et al.Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12[].Cancer Research.1999

同被引文献19

  • 1de Waal MR,Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4 + T,cell clones and resting T cell : specific inhibition of IL-2 production and proliferation. J Immunol, 1993,11:4754 - 4765.
  • 2Gazzinell R T, Oswald I P, James S L, et al. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-',/activated macrophages. J Immunol, 1992,148 : 1792 - 1796.
  • 3Baker K S, Ronearolo M G, Petem C, et al. High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications an d early deaths. Bone Marrow Transplant, 1999,23 : 1123 - 1129.
  • 4Coughlin C M,Salhang K E, Gee M S, et al. Tumor cell responses to IFN gamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity, 1998,1:25 - 34.
  • 5Wigginton J M, Gruys E, Geiselhart L, et al. TFN-gamma and Fas! FasL are required for the antitumor and antiangiogenic effects of IL- 12/pulse IL-2 therapy. J Clin Invest,2001,1:51 -62.
  • 6Stern A S,Magram J,Presky D H. IL-12: an integral cytokine in the immune response. Life Sci, 1996,58:639 - 654.
  • 7Lucey D R, Clerici M, Shearer G M. Type 1 and Type 2 cytokine dys- regulation to human infection Neoplastic and inflammatory disease. Clin Microbiol Rev, 1996,4:532 - 562.
  • 8Sharama S, Stolina M, Lin Y, et al. T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function. J Immunol, 1999,9:5020 - 5028.
  • 9Kakumu S, Okumura A, Ishikawa T, et al. Production of IL-10 and 12 by periheral blood mononuclear cell s in chronic hepatitis C virus infection. Clin Exp Immunol, 1997,108 : 138 - 143.
  • 10Lissioni P, Rovelli F, Fumagalli L, et al. Increased blood concentra- tions of interleukin-12 are associated with a longer survival in untreat- able metastatic solid tumor patients:preliminary observations. 1 nt J Bi- ol Markers, 1997,3 : 125 - 127.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部